We acknowledge the exclusion of albumin‐to‐creatinine ratio as a limitation and recommend that future studies incorporate both eGFR and albumin‐to‐creatinine ratio to better elucidate the interplay between haemodynamic and renal dysfunction in cardiovascular risk stratification frameworks for survivors of cancer. The gene discussed is ALB; the disease is cancer.